Cargando…
Lipotoxicity as a Barrier for T Cell-Based Therapies
Nowadays, T-cell-based approaches play an increasing role in cancer treatment. In particular, the use of (genetically engineered) T-cells has heralded a novel era for various diseases with previously poor outcomes. Concurrently, the relationship between the functional behavior of immune cells and th...
Autores principales: | Böttcher-Loschinski, Romy, Rial Saborido, Judit, Böttcher, Martin, Kahlfuss, Sascha, Mougiakakos, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496045/ https://www.ncbi.nlm.nih.gov/pubmed/36139021 http://dx.doi.org/10.3390/biom12091182 |
Ejemplares similares
-
TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
por: Jantz-Naeem, Nouria, et al.
Publicado: (2023) -
CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints
por: Böttcher, Martin, et al.
Publicado: (2022) -
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner
por: Loschinski, Romy, et al.
Publicado: (2018) -
Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment
por: Häselbarth, Lukas, et al.
Publicado: (2023) -
“Moonlighting” at the power plant: how mitochondria facilitate serial killing by CD8(+) cytotoxic T cells
por: Mougiakakos, Dimitrios, et al.
Publicado: (2021)